Takhzyro® (lanadelumab-flyo)
for Hereditary Angioedema

Takhzyro (lanadelumab-flyo) is used to prevent swelling attacks in people with hereditary angioedema (HAE). It works by blocking kallikrein, a protein that increases levels of bradykinin, which causes swelling and pain during HAE attacks. By reducing bradykinin, Takhzyro helps prevent symptoms such as abdominal pain, vomiting, or rapid swelling of the face, limbs, or throat.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hereditary Angioedema - HAE